Skip to main content

Profit booking at higher levels, pharma, defence stocks shine

Top Nifty gainers included Tata Motors, M&M, L&T, and Cipla.

 

Indian markets witnessed mild profit-booking at higher levels on August 10 but closed comfortably in the green, as the S&P BSE Sensex rallied more than 100 points while the Nifty50 went past 11,250.

The S&P BSE Sensex ended the day 141 points higher at 38,182, while the Nifty50 rose 56 points to close at 11,270.

The broader markets outperformed the benchmarks. The S&P BSE Midcap index rose 1.4 percent, while the S&P BSE Smallcap index ended with gains of 1.47 percent.

Related News 

Pharma stocks rally led by Divis Labs, Cipla; Lupin, Sun Pharma gain 3% each

Pharma stocks remained in the limelight as Dr Reddy’s (up 2.5 percent), Divi’s Laboratories (up 11 percent), Torrent Pharma (up 2.3 percent), Ipca Laboratories (up 7 percent), Lupin (up 8 percent), and Cipla (up 9 percent) hit a new 52-week high.

Defence stocks rallied after the ministry came out with a list of 101 items that will no longer be imported. Among Sensex constitutents, L&T was the top gainer, up nearly 5 percent.

“Sectoral news flow boosted positivity in the Indian markets, with the pharma index leading the gains. The gains were news-driven, with earnings results and government actions accounting for sectoral gains,” Vinod Nair, Head of Research at Geojit Financial Services told Moneycontrol.


“Earnings results of select pharma companies drove gains in the sector while government actions to boost domestic defence productions helped gains in defence stocks. With valuations are going high, investors are advised to remain cautious and nimble with their investments,” he said.

Sectorally, action was seen in healthcare, capital goods, realty, industrials, and utilities, while profit-taking was visible in energy and oil & gas stocks.

Top Nifty gainers included Tata Motors, M&M, L&T and Cipla.

Top Nifty losers included RIL, Asian Paints and Eicher Motors.

Stocks & Sectors

Sectorally, the S&P BSE Healthcare index rose 4.6 percent followed by the S&P BSE Capital Goods index that was up 3.3 percent and the S&P BSE Realty index closed with gains of 2.7 percent.

Volume spike of more than 100 percent was seen in stocks like BHEL, Dabur India, Divi’s Laboratories, Amara Raja Batteries, and Container Corp.

Long buildup was seen in stocks like Bharat Forge, Motherson Sumi and Cipla.

Short buildup was seen in stocks like Container Corp, Bata India, and Bajaj Finance.

More than 200 stocks on the BSE hit their fresh 52-week high. Among them were Bharat Rasayan, Wabco India, SRF, Info Edge and VST Tillers.

Stocks in news

Cipla stock jumped almost 10 percent after the company reported its June quarter earnings after the market hours on August 7.

Tejas Networks shares jumped 5 percent after the company bagged a Rs 66-crore order from L&T Construction.

IPCA Laboratories stock jumped over 7 percent after the company reported a consolidated net profit of Rs 445.7 crore against Rs 129.4 crore YoY.

Cochin Shipyard share price gained over 3 percent as the company posted a 65 percent YoY fall in its consolidated net profit at Rs 41.4 crore against Rs 119 crore.

Shipping Corporation Of India stock price jumped almost 7 percent after the company reported a net profit of Rs 336.87 crore in the June quarter against a net loss of Rs 28.90 crore in June 2019.

Technical View

The Nifty formed a Doji candle on the daily scale, indicating the absence of follow-up action at key resistance zones.

It has to continue to hold above 11,200 to witness an upmove towards recent swing highs of 11,341 then 11,500. On the downside, support exists at 11,150 then 11,100 zones, said Chandan Taparia of Motilal Oswal Financial Services Limited.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com/SDSolutions advises users to check with certified experts before taking any investment decisions.

Source - Moneycontrol.com

Labels:

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more